Atopic Dermatitis: Rocatinlimab Study

We are investigating the long-term safety and effectiveness of rocatinlimab for adults and adolescents with moderate-to-severe atopic dermatitis. The study compares the treatment's effects to a placebo in those who have previously responded to the medication.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Rocatinlimab

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
Department for Dermatology and Venereology
Graz, Austria
Gemeinnutzige Salzburger Landes kliniken Betriebsgesellschaft mbH
Department of Dermatology
Salzburg, Austria
UZ Brussel
Dermatology
Ganshoren, Belgium

Sponsor: Amgen Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.